11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli
(
- Contribution to journal › Article
-
Mark
Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus
(
- Contribution to journal › Article
- 1994
-
Mark
Site-directed primary in vitro immunization : Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
(
- Contribution to journal › Article
-
Mark
Intra- and extracellular expression of an scFv antibody fragment in E. coli : Effect of bacterial strains and pathway engineering using GroES/L chaperonins
(
- Contribution to journal › Article
- 1993
-
Mark
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
(
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
(
- Contribution to journal › Article
- 1992
-
Mark
Epstein-Barr virus-induced transformation of human B lymphocytes : the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations
(
- Contribution to journal › Article
-
Mark
Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope
(
- Contribution to journal › Article
- 1990
-
Mark
Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
(
- Contribution to journal › Article
-
Mark
Systemic and intraocular uptake of spantide, a tachykinin antagonist, following topical application to the rabbit eye.
(
- Contribution to journal › Article